科兴制药: 关于变更注册资本、取消监事会、修订《公司章程》并办理工商变更登记、修订及制定公司部分治理制度的公告

Group 1 - The company has decided to cancel the supervisory board and allow the audit committee of the board to exercise the powers of the supervisory board as per the new Company Law regulations [1][2][3] - The company will revise its articles of association to reflect the cancellation of the supervisory board and update related governance systems [2][3] - The second supervisory board will continue to perform its supervisory duties until the shareholders' meeting approves the cancellation [2] Group 2 - The company's registered capital has been increased from RMB 199,642,250 to RMB 201,257,250 following the completion of the first vesting period of the restricted stock incentive plan [2][3] - The total number of shares has changed from 199,642,250 to 201,257,250 shares [2] Group 3 - The company is revising its articles of association to enhance operational standards and comply with relevant regulations, including the new Company Law and the Shanghai Stock Exchange rules [3][6] - The revised articles will include new or deleted sections and clauses, with the remaining provisions unchanged [3][6] - The revised articles will be disclosed on the Shanghai Stock Exchange website [3][6] Group 4 - Several governance systems have been revised to improve the company's governance structure and ensure compliance with legal requirements [3][5] - The revised governance systems will be effective after approval from the shareholders' meeting [5][6]